Antibacterial and Antibiofilm Activities of Novel Antimicrobial Peptides against Multidrug-Resistant Enterotoxigenic Escherichia Coli. 2021

Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
Department of Biotechnology and Animal Science, National Ilan University, Yilan 26047, Taiwan.

Post-weaning diarrhea due to enterotoxigenic Escherichia coli (ETEC) is a common disease of piglets and causes great economic loss for the swine industry. Over the past few decades, decreasing effectiveness of conventional antibiotics has caused serious problems because of the growing emergence of multidrug-resistant (MDR) pathogens. Various studies have indicated that antimicrobial peptides (AMPs) have potential to serve as an alternative to antibiotics owing to rapid killing action and highly selective toxicity. Our previous studies have shown that AMP GW-Q4 and its derivatives possess effective antibacterial activities against the Gram-negative bacteria. Hence, in the current study, we evaluated the antibacterial efficacy of GW-Q4 and its derivatives against MDR ETEC and their minimal inhibition concentration (MIC) values were determined to be around 2~32 μg/mL. Among them, AMP Q4-15a-1 with the second lowest MIC (4 μg/mL) and the highest minimal hemolysis concentration (MHC, 256 μg/mL), thus showing the greatest selectivity (MHC/MIC = 64) was selected for further investigations. Moreover, Q4-15a-1 showed dose-dependent bactericidal activity against MDR ETEC in time-kill curve assays. According to the cellular localization and membrane integrity analyses using confocal microscopy, Q4-15a-1 can rapidly interact with the bacterial surface, disrupt the membrane and enter cytosol in less than 30 min. Minimum biofilm eradication concentration (MBEC) of Q4-15a-1 is 4× MIC (16 μg/mL), indicating that Q4-15a-1 is effective against MDR ETEC biofilm. Besides, we established an MDR ETEC infection model with intestinal porcine epithelial cell-1 (IPEC-1). In this infection model, 32 μg/mL Q4-15a-1 can completely inhibit ETEC adhesion onto IPEC-1. Overall, these results suggested that Q4-15a-1 may be a promising antibacterial candidate for treatment of weaned piglets infected by MDR ETEC.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001422 Bacterial Adhesion Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity. Adhesion, Bacterial,Adhesions, Bacterial,Bacterial Adhesions
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D013553 Swine Diseases Diseases of domestic swine and of the wild boar of the genus Sus. Disease, Swine,Diseases, Swine,Swine Disease
D052899 Pore Forming Cytotoxic Proteins Proteins secreted from an organism which form membrane-spanning pores in target cells to destroy them. This is in contrast to PORINS and MEMBRANE TRANSPORT PROTEINS that function within the synthesizing organism and COMPLEMENT immune proteins. These pore forming cytotoxic proteins are a form of primitive cellular defense which are also found in human LYMPHOCYTES.
D054307 Enterotoxigenic Escherichia coli Strains of ESCHERICHIA COLI that produce or contain at least one member of either heat-labile or heat-stable ENTEROTOXINS. The organisms colonize the mucosal surface of the small intestine and elaborate their enterotoxins causing DIARRHEA. They are mainly associated with tropical and developing countries and affect susceptible travelers to those places. E coli, Enterotoxigenic,ETEC,Escherichia coli, Enterotoxigenic,Enterotoxigenic E. coli
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm

Related Publications

Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
July 2022, International journal of molecular sciences,
Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
July 2018, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
January 2023, Future microbiology,
Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
January 2022, Frontiers in microbiology,
Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
January 2017, Drug design, development and therapy,
Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
November 2022, International journal of molecular sciences,
Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
January 2024, Microbiological research,
Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
March 2022, Acta biochimica et biophysica Sinica,
Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
June 2024, International journal of pharmaceutics,
Kang-Chi Wu, and Kuo-Feng Hua, and Yu-Hsiang Yu, and Yeong-Hsiang Cheng, and Ting-Ting Cheng, and Yao-Kuan Huang, and Hui-Wen Chang, and Wei-Jung Chen
August 2022, International journal of molecular sciences,
Copied contents to your clipboard!